ORGO Q3 2017 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$3M

Net Income

-$2M

EPS (Diluted)

$-0.23

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$543,730

Free Cash Flow

-$543,730

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$312M

Total Liabilities

$14M

Stockholders' Equity

$299M

Cash & Equivalents

$117,728

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$14,492	-19587.6%
Operating Income	-$3M	-$14,492	-19587.6%
Net Income	-$2M	-$14,492	-14508.1%